No Data
No Data
No Data
No Data
No Data
NK Cell Therapies Pipeline Report 2024: Insights on 80+ Companies and 100+ Pipeline Drugs, Including ALECSAT (CytoVac), NKTR-214/Bempegaldesleukin (Nektar Therapeutics), and Monalizumab (Innate Pharma)
Yahoo FinanceApr 26 16:12
Nektar Therapeutics Receives Letter That It Has Regained Compliance With Minimum Bid Price Requirement For Continued Listing On Nasdaq Capital Market - Filing
To regain compliance with the Minimum Bid Price Requirement, the Company's common stock was required to maintain a closing bid price of $1.00 per share or greater for at least 10 consecutive business
BenzingaApr 18 05:16
NKTR, VERU and EGIO Among Mid-day Movers
Seeking AlphaApr 12 00:55
Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?
Yahoo FinanceApr 3 23:30
Nektar Therapeutics Is Worried About This – Should You Be Worried Too?
TipRanksMar 7 14:00
Nektar Therapeutics Is Maintained at Hold by Jefferies
Nektar Therapeutics Is Maintained at Hold by Jefferies
Dow JonesMar 6 22:54
No Data
No Data